FierceBiotech· @FierceBiotech · X·· 2 天前AI 评分42
AI 导读
Tolerance Bio 以5.6亿美元从田边三菱制药引进一款抗IL-33药物，持续推进其以胸腺为核心的管线布局。
正文
Tolerance Bio has continued to strengthen its thymus-focused pipeline by picking up an anti-IL-33 drug from Tanabe Pharma. https://www.fiercebiotech.com/biotech/tolerance-continues-thymus-focused-deals-560m-pact-tanabe
来源：FierceBiotech · x.com